Baker Tilly Wealth Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,212
Closed -$286K 369
2024
Q1
$286K Buy
+7,212
New +$285K 0.05% 353
2023
Q2
Sell
-4,610
Closed -$201K 567
2023
Q1
$201K Sell
4,610
-818
-15% -$36.1K 0.02% 523
2022
Q4
$202K Sell
5,428
-395
-7% -$15.3K 0.02% 509
2022
Q3
$232K Sell
5,823
-342
-6% -$12.7K 0.03% 452
2022
Q2
$236K Sell
6,165
-146
-2% -$5.28K 0.03% 445
2022
Q1
$250K Buy
+6,311
New +$247K 0.03% 456

Other funds holding NRC

Baker Tilly Wealth Management's NRC Position: Q2 2024 in Review

Baker Tilly Wealth Management sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 7,212 shares — an estimated $286K sold.

Baker Tilly Wealth Management first reported a position in NRC in Q1 2022 and held it in 6 quarters. The position peaked at $286K in Q1 2024. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Baker Tilly Wealth Management reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 7,212 NRC Health Common Stock shares in Q2 2024, an estimated $286K.
  • Baker Tilly Wealth Management first reported a position in NRC Health Common Stock in Q1 2022 and held it in 6 quarters.
  • Baker Tilly Wealth Management's NRC Health Common Stock position peaked at $286K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2024, filed 18 Jul 2024.